Metacognitive interpersonal therapy in group versus TAU + waiting list for young adults with personality disorders: Randomized clinical trial.
Raffaele PopoloAngus MacBethLuana LazzeriniStefano BrunelloGloria VenturelliDaniela RebecchiMaria Francisca MoralesGiancarlo DimaggioPublished in: Personality disorders (2021)
Young adults presenting with personality disorders (PDs) featuring overcontrol and social inhibition urgently require effective psychological interventions to help them navigate important life transitions. metacognitive interpersonal therapy-group (MIT-G) is a time-limited group program designed to enable individuals to find adaptive solutions to their social difficulties. A small randomized clinical trial (RCT) of MIT-G versus treatment as usual (TAU) was conducted with the primary outcomes of improvements in social and interpersonal functioning and global psychological symptoms. Secondary outcomes were specific symptoms of anxiety and depression and changes in alexithymia and emotion dysregulation. From 40 participants, 20 were randomized to 16 weekly sessions of MIT-G, plus 3 individual sessions and 20 to TAU + waiting list. All 20 patients allocated to MIT-G completed treatments, while 2 dropped-out in the TAU arm. Patients in the MIT-G arm reported significant improvements on primary outcomes of functioning, interpersonal problems and global symptoms of medium magnitude, medium effect sizes for changes in depression and anxiety, and large magnitude changes for alexithymia. However, other than alexithymia no significant differences were observed between groups at treatment end. A Time × Condition interaction, indicated that MIT-G was associated with more rapid and larger magnitude improvements in functioning and alexithymia. MIT-G is a well-tolerated treatment option for young adults with overcontrolled PD. Further effectiveness studies in larger samples are underway. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Keyphrases
- end stage renal disease
- mental health
- young adults
- ejection fraction
- healthcare
- cerebrospinal fluid
- prognostic factors
- sleep quality
- randomized controlled trial
- autism spectrum disorder
- adipose tissue
- clinical trial
- peritoneal dialysis
- open label
- patient reported outcomes
- insulin resistance
- bone marrow
- middle aged
- weight loss
- quality improvement
- study protocol